140 patents currently held
72 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Mar 2027. from the record
Of the 72 now held by other companies, 17 name Thruchip Japan Inc. as their current owner, and 55 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
6
Ending by 2030
Mar 2027
Next term end
120
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2033 · High confidence
Also notable
Ends Dec 2037 · High confidence
Also notable
Ends Aug 2037 · High confidence
Directional Coupling Communication Apparatus
US 10,291,290
The most cited patent in this portfolio, cited by 109 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2033.
Compositions and Methods for the Induction of CD8+ T-Cells
US 10,695,412
Cited by 9 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Method For Differentiating Pluripotent Stem Cells Into Desired Cell Type
US 10,836,997
Cited by 10 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037.
Formerly held, still cited
Notable
Ends May 2030 · High confidence
Cited by 61 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
now held by Toyobo Co., Ltd.
Also notable
Ends Dec 2037 · High confidence
Cited by 10 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2037.
now held by The University of Tokyo
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 4 to 25, 2026 · next Dec 4
- 2 fees due Jan 9 to 11, 2027 · next Jan 9
- 5 fees due Feb 1 to 28, 2027 · next Feb 1
- 2 fees due Mar 19 to 24, 2027 · next Mar 19
- 2 fees due May 19 to 26, 2027 · next May 19
- 7 fees due Jun 5 to 29, 2027 · next Jun 5
- 4 fees due Jul 2 to 16, 2027 · next Jul 2
- 5 fees due Aug 4 to 18, 2027 · next Aug 4
- 3 fees due Sep 3 to 15, 2027 · next Sep 3
- 2 fees due Oct 9 to 16, 2027 · next Oct 9
- 2 fees due Nov 5, 2027
Recent changes
- 7 of the patents on this record were granted since Aug 18, 2026
- 2 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 120 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method Of Deriving Lacrimal Gland Epithelial Cells From ES Cells And Other Stem Cells | 8 in force | to May 2038 |
| Cell Culture Medium for Culturing Organoid, Culture Method, and Organoid | 3 in force | to Oct 2039 |
| Compositions and Methods for the Induction of CD8+ T-Cells | 3 in force | to Dec 2037 |
| Klebsiella Pneumoniae Strain Inducing Inflammation in Liver | 2 in force | to Nov 2039 |
| Infrared Analysis System, Infrared Analysis Chip, and Infrared Imaging Device | 2 in force | to Aug 2039 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,518,880 | Therapeutic Agent for Spinal Cord Injuries In force · High confidence | In force | High confidence | |
| US 7,964,177 | Method for Determination of Oxidative Stress In force · High confidence | In force | High confidence | |
| US 7,915,802 | Surface Light Emitting Device and Polarization Light Source held by Rohm Co., Ltd. and Keio University In force · High confidence | In force | High confidence | |
| US 8,592,643 | Methods for Introducing a Human Gene into a Marmoset Embryo for Making a Transgenic Marmoset In force · High confidence | In force | High confidence | |
| US 8,841,250 | A Method for Promoting Muscle Repair Comprising Administering G-Csf at the Site of Injury In force · Medium confidence | In force | Medium confidence | |
| US 8,877,222 | Antibacterial Medical Equipment and Method for Producing the Same held by Meiji University and Keio University In force · High confidence | In force | High confidence | |
| US 9,029,513 | Anti-Egfr Antibody and Use Thereof held by Toagosei Co. Ltd. and Keio University In force · High confidence | In force | High confidence | |
| US 8,895,997 | Carbon Nanotube Light Emitting Device, Light Source, and Photo Coupler In force · High confidence | In force | High confidence | |
| US 9,419,684 | Inter-Module Communication Apparatus In force · High confidence | In force | High confidence | |
| US 10,309,957 | A Method for Determining Sensitivity to Fluorouracil in a Subject Having Colorectal Cancer held by Kabushiki Kaisha Yakult Honsha In force · High confidence | In force | High confidence |
Also on record, not counted in the 140: 72 patents in force now held by others · 166 patents ended · 154 applications pending · 225 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.